UBS Group
TDOC icon

UBS Group’s Teladoc Health TDOC Stock Holding History

UBS Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,800
Closed -$184K – 11144
2025
Q3 		$184K Buy
+23,800
New +$186K ﹤0.01% 6721
2025
Q2 		– Sell
-89,100
Closed -$709K – 10817
2025
Q1 		$709K Sell
89,100
-100,000
-53% -$1.01M ﹤0.01% 5576
2024
Q4 		$1.72M Buy
189,100
+89,100
+89% +$860K ﹤0.01% 4867
2024
Q3 		$918K Sell
100,000
-51,100
-34% -$423K ﹤0.01% 4735
2024
Q2 		$1.48M Hold
151,100
– – ﹤0.01% 4057
2024
Q1 		$2.28M Sell
151,100
-33,400
-18% -$606K ﹤0.01% 3815
2023
Q4 		$3.98M Sell
184,500
-75,000
-29% -$1.38M ﹤0.01% 3023
2023
Q3 		$4.82M Sell
259,500
-425,500
-62% -$9.93M ﹤0.01% 2604
2023
Q2 		$17.3M Sell
685,000
-150,000
-18% -$3.78M 0.01% 1555
2023
Q1 		$21.6M Sell
835,000
-435,600
-34% -$11.7M 0.01% 1335
2022
Q4 		$30M Buy
1,270,600
+109,100
+9% +$2.94M 0.01% 1136
2022
Q3 		$29.4M Sell
1,161,500
-293,625
-20% -$10.3M 0.01% 1016
2022
Q2 		$48.3M Buy
1,455,125
+108,325
+8% +$4.6M 0.02% 750
2022
Q1 		$97.1M Sell
1,346,800
-592,600
-31% -$42.7M 0.03% 531
2021
Q4 		$178M Buy
1,939,400
+1,296,401
+202% +$155M 0.05% 378
2021
Q3 		$81.5M Buy
642,999
+23,400
+4% +$3.41M 0.03% 615
2021
Q2 		$103M Sell
619,599
-66,313
-10% -$10.7M 0.03% 508
2021
Q1 		$125M Buy
685,912
+598,412
+684% +$139M 0.04% 423
2020
Q4 		$17.5M Buy
+87,500
New +$17.8M 0.01% 1435

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's TDOC Position: Q1 2026 in Review

UBS Group increased its Teladoc Health (TDOC) stake by 15% in Q1 2026, buying an estimated $1.28M and bringing the position to 1,726,823 shares worth $9.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3427.

UBS Group first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $112M in Q2 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • UBS Group held 1,726,823 shares of Teladoc Health worth $9.41M as of Q1 2026.
  • UBS Group bought 228,272 Teladoc Health shares in Q1 2026, an estimated $1.28M.
  • Teladoc Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3427 holding.
  • UBS Group first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
  • UBS Group's Teladoc Health position peaked at $112M in Q2 2021.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.